Cargando…
The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)
BACKGROUND: It has been reported the prognostic value of MTV in predicting the disease prognosis of peripheral T-cell lymphoma (PTCL) through pre-treatment PET/CT imaging. However, these are limited data on pretreatment evaluation and prognosis assessments of peripheral T-cell lymphoma-not otherwise...
Autores principales: | Zhang, Yafei, Wang, Guangfa, Zhao, Xin, Hu, Yongxian, Tan Su Yin, Elaine, Chen, Donghe, Wang, Huatao, Zhao, Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501648/ https://www.ncbi.nlm.nih.gov/pubmed/34627196 http://dx.doi.org/10.1186/s12880-021-00674-5 |
Ejemplares similares
-
Molecular understanding of peripheral T-cell lymphomas, not otherwise
specified (PTCL, NOS): A complex disease category
por: Sakata-Yanagimoto, Mamiko, et al.
Publicado: (2021) -
Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) presenting as an endobronchial lesion: Case report and literature review
por: Sueyasu, Takuto, et al.
Publicado: (2018) -
Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy
por: Ohara, Masahiro, et al.
Publicado: (2017) -
Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network
por: Federico, Massimo, et al.
Publicado: (2018) -
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
por: Maura, Francesco, et al.
Publicado: (2020)